[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100195290":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":22,"locations":31,"responsibleParty":45,"collaborators":48,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":22,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":22,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":77,"whyStopped":22,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Henry Ford Health System","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"10% Benzoyl Peroxide Topical Body Wash","ACTIVE_COMPARATOR","Subjects will use 10% benzoyl peroxide twice daily. The product will be applied to the affected areas, left on for 45 seconds, then rinsed off.",[13],"Drug: 10% Benzoyl Peroxide Topical Body Wash",{"label":15,"type":10,"description":16,"interventionNames":17},"Provodine Topical Cream","Subjects will use Provodine Topical Cream twice daily. The product will be applied to the affected areas, left on for 45 seconds, then rinsed off.",[18],"Drug: Provodine Topical Cream",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":22},"DRUG",null,[9],{"type":21,"name":15,"description":22,"armGroupLabels":25,"otherNames":22},[15],[27],{"name":28,"affiliation":29,"role":30},"Iltefat H Hamzavi, MD","Henry Ford Dermatology","PRINCIPAL_INVESTIGATOR",[32],{"facility":33,"status":22,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":22},"Henry Ford Medical Center Department of Dermatology","Detroit","Michigan","48202","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-83.04575,42.33143,{"lat":43,"lon":42},{"type":30,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"Iltefat Hamzavi","Senior Staff Physician",[49],{"name":50,"class":51},"Microdermis Corporation","INDUSTRY","100195290","an-investigation-into-the-efficacy-of-provodine-topical-cream-as-compared-to-10-benzoyl-peroxide-wash-for-the-treatment-of-hidradenitis-suppurativa-100195290",false,"NCT01818167","An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.","A Prospective Multi-Center Blinded, Randomized, Controlled Clinical Trial Comparing the Efficacy of Provodine Topical Body Wash Versus 10% Benzoyl Peroxide Topical Body Wash for the Treatment of Hidradenitis Suppurativa","Inclusion Criteria:\n\n* For inclusion, the subject must:\n\n  1. Be at least 13 years old.\n  2. Be otherwise healthy.\n  3. Have a diagnosis of HS.\n  4. Patients must have Hurley stage I or Stage II HS\n  5. Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form.\n  6. Agree to follow and undergo all study-related procedures.\n  7. If applicable, minors must have permission of legal guardian for participation in the study.\n\nExclusion Criteria:\n\n* Subjects who meet the following criteria will be excluded:\n\n  1. Patients with HS Hurley stage III will be excluded from participation in the study\n  2. Patients who are pregnant or breast feeding will not be able to take part in the study due to the unknown effects of the topical medications.\n  3. Concomitant use of systemic or other topical treatments for HS not involved in current study. For cohort I, no washout period for systemic and\u002For topical medications will be required. For Cohort II, there will be a 14 day minimum washout period for systemic and topical treatments for HS.\n  4. Any reason the investigator feels the patient should not participate in the study.\n  5. If a patient misses ≥ 2 consecutive study visits, the patient will be excluded from further participation in this trial.\n  6. History of allergy to iodine or benzoyl peroxide.",true,"ALL","13 Years","120 Years",{"count":64,"type":65},25,"ACTUAL","INTERVENTIONAL",[68],"NA","The purpose of this study is to compare the efficacy of Provodine™ topical cream to 10% benzoyl peroxide topical body wash for the treatment of early stage hidradenitis suppurativa.",[71],"Hidradenitis Suppurativa",[71,73,74,75,76],"HS","Acne Inversa","Velpeau's disease","Verneuil's disease","COMPLETED","2022-02-15",{"date":80,"type":65},"2022-02-16",{"date":82,"type":65},"2013-01-05",{"date":84,"type":65},"2015-01-21",{"name":5,"class":6},1]